Ardelyx, Inc. (ARDX)
6.23
-0.23
(-3.56%)
USD |
NASDAQ |
May 15, 16:00
6.23
0.00 (0.00%)
After-Hours: 20:00
Ardelyx EPS Diluted (Quarterly) : -0.153 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| PTC Therapeutics, Inc. | -0.034 |
| Syndax Pharmaceuticals, Inc. | -0.4835 |
| Akebia Therapeutics, Inc. | -0.0339 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.60M |
| Revenue (Quarterly) | 94.47M |
| Total Expenses (Quarterly) | 132.08M |
| Enterprise Value | 1.509B |
| Gross Profit Margin (Quarterly) | 93.94% |
| Profit Margin (Quarterly) | -39.80% |
| Earnings Yield | -3.82% |
| Normalized Earnings Yield | -3.823 |